A group of researchers conducted various studies on hepatitis C incidence and prevalence. They noticed that there is a high prevalence of hepatitis C in third-world countries, where it has a significant impact on the quality of life of the infected individual. The research group made several attempts to produce a vaccine that prevents hepatitis C infection but all attempts failed. Which of the following would most likely be the reason for the failure to produce a vaccine?
A 13-year-old boy presents to the pediatrician with yellow discoloration of the sclerae since yesterday, and dark-colored urine for 2 days. A detailed history is taken and reveals that he had a cough, cold, and fever the week before the onset of the current symptoms, and was treated with over-the-counter medications. He reports an improvement in his upper respiratory symptoms but has been experiencing fatigue, nausea, and poor appetite since then. There is no past history of recurrent nausea, vomiting, jaundice or abdominal pain, and he has not received any blood transfusion. In addition, he frequently eats at a roadside restaurant near his school. His growth and development are normal for his age and sex. The temperature is 37.9°C (100.2°F), pulse is 96/min, blood pressure is 110/70 mm Hg, and the respiratory rate is 22/min. The physical examination shows icterus. The examination of the abdomen reveals tender hepatomegaly with the liver having a firm, sharp, and smooth edge. The laboratory test results are as follows: Hemoglobin 14.2 g/dL WBC (white blood cell) 10,500/mm3 Differential leukocyte count Segmented neutrophils 56% Bands 4% Lymphocytes 35% Eosinophils 2% Basophils 0% Monocytes 3% Platelet count 270,000/mm3 Serum total bilirubin 8.4 mg/dL Serum direct bilirubin 7.8 mg/dL Serum alanine aminotransferase 350 U/L Serum alkaline phosphatase 95 U/L Prothrombin time 20 seconds Which of the following laboratory tests is most likely used to diagnose the condition of this patient?
A scientist is studying the replication sequences of a number of different viruses. He observes that one particular virus he is studying creates a single stranded DNA from an RNA template during its replication sequence. Which of the following viruses is he most likely observing?
A previously healthy 25-year-old woman comes to the physician because of a one-week history of diffuse abdominal pain. Her temperature is 39.1°C (102.3°F). Physical examination shows numerous scars and excoriations along both arms, scleral icterus, and tender hepatomegaly. Serum studies show: Alanine aminotransferase 927 U/L Aspartate aminotransferase 796 U/L Hepatitis B surface antigen positive Hepatitis B surface antibody negative Anti-hepatitis B core antibody positive Hepatitis C antibody negative Which of the following is the most likely outcome of this patient's infection?
A 25-year-old construction worker presents to the office due to a yellowish discoloration of his skin and eyes for the past 2 weeks. He also complains of nausea and loss of appetite for the same duration. The past medical history is insignificant. He is a smoker, but recently has grown a distaste for smoking. The vital signs include: heart rate 83/min, respiratory rate 13/min, temperature 36.5°C (97.7°F), and blood pressure 111/74 mm Hg. On physical examination, there is mild hepatomegaly. The results of the hepatitis viral panel are as follows: Anti-HAV IgM positive HBsAg negative IgM anti-HBc negative Anti-HCV negative HCV-RNA negative Anti-HDV negative Anti-HEV negative What is the most common mode of transmission for this patient’s diagnosis?
A 32-year-old man presents to the physician with a history of fever, malaise, and arthralgia in the large joints for the last 2 months. He also mentions that his appetite has been significantly decreased during this period, and he has lost considerable weight. He also informs the physician that he often experiences tingling and numbness in his right upper limb, and his urine is also dark in color. The past medical records show that he was diagnosed with an infection 7 months before and recovered well. On physical examination, the temperature is 37.7°C (99.8°F), the pulse rate is 86/min, the respiratory rate is 14/min, and the blood pressure is 130/94 mm Hg. Which of the following infections has most likely caused the condition the patient is suffering from?
A 28-year-old man comes to the physician because of progressively worsening fatigue, nausea, and right upper quadrant pain. He has a history of intravenous heroin use. Serum Anti-HBc is positive. Further analysis of the Anti-HBc immunoglobulin in this acute presentation is most likely to show which of the following properties?
A 27-year-old woman who recently emigrated from Brazil comes to the physician because of fever, fatigue, decreased appetite, and mild abdominal discomfort. She has not seen a physician in several years and her immunization status is unknown. She drinks 2 alcoholic beverages on the weekends and does not use illicit drugs. She is sexually active with several male partners and uses condoms inconsistently. Her temperature is 38°C (99.8°F). Physical examination shows right upper quadrant tenderness and scleral icterus. Serology confirms acute infection with a virus that has partially double-stranded, circular DNA. Which of the following is most likely involved in the replication cycle of this virus?
A 57-year-old man comes to the physician because of generalized malaise, yellowish discoloration of the eyes, and pruritus on the back of his hands that worsens when exposed to sunlight for the past several months. He has not seen a physician in 15 years. Physical examination shows scleral icterus and mild jaundice. There is a purpuric rash with several small vesicles and hyperpigmented lesions on the dorsum of both hands. The causal pathogen of this patient's underlying condition was most likely acquired in which of the following ways?
A 59-year-old man comes to the physician for the evaluation of generalized fatigue, myalgia, and a pruritic skin rash for the past 5 months. As a child, he was involved in a motor vehicle accident and required several blood transfusions. Physical examination shows right upper abdominal tenderness, scleral icterus, and well-demarcated, purple, polygonal papules on the wrists bilaterally. Laboratory studies show an elevated replication rate of a hepatotropic virus. Further analysis shows high variability in the genetic sequence that encodes the glycosylated envelope proteins produced by this virus. Which of the following is the most likely explanation for the variability in the genetic sequence of these proteins?
Explanation: ***Antigenic variation*** - The **hepatitis C virus (HCV)** undergoes rapid **antigenic variation**, particularly in its envelope glycoproteins, which allows it to evade the host immune system. - This high mutation rate presents a significant challenge for vaccine development, as a vaccine designed against one viral strain may not be effective against others. *Non-DNA genome* - While HCV is an **RNA virus** (non-DNA genome), this characteristic alone does not inherently prevent vaccine development; many effective RNA virus vaccines exist (e.g., measles, mumps). - The type of genome is less critical than its stability and the virus's ability to mutate rapidly. *Tolerance* - **Immune tolerance** occurs when the immune system fails to respond to an antigen, often due to chronic exposure. While relevant in chronic HCV infection, it's not the primary reason for vaccine failure. - The goal of a vaccine is to induce an effective immune response before tolerance can set in. *Antigenic mimicry* - **Antigenic mimicry** involves a pathogen's antigens resembling host antigens, potentially leading to autoimmune responses or immune evasion. - While it can be a factor in some chronic infections, the rapid, diverse changes in HCV's surface antigens are a more prominent obstacle to vaccine design. *Polysaccharide envelope* - HCV is an **enveloped virus**, but its envelope is composed of **lipoproteins** with viral glycoproteins, not a polysaccharide capsule. - Polysaccharide capsules are a feature of some bacteria (e.g., Streptococcus pneumoniae) and fungi, and while they can pose vaccine challenges, they are not relevant to HCV.
Explanation: ***Serum anti-HAV IgM antibody*** - The patient's symptoms (jaundice, dark urine, fatigue, nausea, tender hepatomegaly) following an upper respiratory illness, especially with a history of eating at a roadside restaurant, are highly suggestive of **acute hepatitis A infection**. - **IgM antibodies** to hepatitis A virus (HAV) are detectable early in the course of infection and indicate **acute or recent infection**, making it the most appropriate diagnostic test. *Plasma tyrosine and methionine* - These tests are used in the diagnosis of **tyrosinemia**, a rare inherited metabolic disorder that can cause liver failure. - The patient's acute presentation and history of potential exposure to HAV make tyrosinemia less likely, and **elevated transaminases** are not specific to tyrosinemia. *Quantitative assay for glucose-6-phosphate dehydrogenase (G6PD) activity* - This assay is used to diagnose **G6PD deficiency**, an inherited condition that can cause hemolytic anemia, particularly after exposure to certain drugs or foods, which might lead to jaundice from unconjugated hyperbilirubinemia. - However, the patient's presentation with **tender hepatomegaly**, conjugated hyperbilirubinemia (direct bilirubin significantly elevated), and elevated transaminases is more consistent with **hepatocellular injury** rather than hemolysis. *Urine for reducing substances* - This test is used to screen for **galactosemia** or other disorders of carbohydrate metabolism in infants and young children, where undigested sugars appear in the urine. - It is not indicated for the diagnosis of acute hepatitis in an adolescent with the presented clinical picture. *Percutaneous liver biopsy* - While a liver biopsy can provide definitive information about liver pathology, it is an **invasive procedure** and is generally not the initial diagnostic test for acute viral hepatitis due to its risks. - **Serological markers** for viral hepatitis are less invasive and usually sufficient for diagnosing acute hepatitis A.
Explanation: ***Hepatitis B virus*** - This virus is a **DNA virus** that replicates via an **RNA intermediate**, using a **reverse transcriptase** enzyme to synthesize DNA from an RNA template. - Its replication cycle involves creating a pre-genomic RNA from its DNA genome, which is then reverse-transcribed into **partially double-stranded DNA** for packaging into new virions. *Hepatitis C virus* - This is an **RNA virus** that replicates entirely within the cytoplasm and does not utilize a DNA intermediate or reverse transcriptase. - Its replication involves the synthesis of a **negative-sense RNA strand** from the positive-sense genomic RNA, which then serves as a template for new positive-sense RNA genomes. *Norovirus* - This is a **positive-sense, single-stranded RNA virus** that replicates in the cytoplasm of host cells. - It uses an **RNA-dependent RNA polymerase** to synthesize new RNA genomes directly from an RNA template, without a DNA intermediate. *HSV-1* - **Herpes Simplex Virus type 1 (HSV-1)** is a **double-stranded DNA virus** that replicates in the nucleus of infected cells. - Its replication pathway involves **DNA-dependent DNA polymerase** to replicate its genome and does not involve an RNA to DNA transcription step. *Hepatitis A virus* - This is a **positive-sense, single-stranded RNA virus** that belongs to the **Picornaviridae family**. - Like other RNA viruses, it replicates its genome via an **RNA-dependent RNA polymerase**, directly creating new RNA copies from an RNA template without a reverse transcription step.
Explanation: ***Transient infection*** - The patient has classic signs of **acute hepatitis B viral infection** (**icterus**, **tender hepatomegaly**, very high **ALT/AST**), and the serology (HBsAg+, anti-HBc+, HBsAb-) confirms an acute infection. - The majority of immunocompetent adults (95%) with acute HBV infection will have a **transient infection** that resolves completely, leading to seroconversion (HBsAb+ and HBsAg- later). *Fulminant hepatitis* - While possible in acute HBV, **fulminant hepatitis** is rare (less than 1%) and characterized by rapid liver failure with **hepatic encephalopathy** and coagulopathy, which are not described. - The patient's symptoms, though severe, do not meet the criteria for fulminant liver failure. *Asymptomatic carrier state* - An **asymptomatic carrier state** usually occurs when the immune system fails to clear the virus, leading to chronic infection with persistent HBsAg. - While this is a possibility for some individuals, the patient's severe symptoms and high transaminase levels indicate an active, acute infection, not an asymptomatic carrier status. *Hepatocellular carcinoma* - **Hepatocellular carcinoma (HCC)** is a long-term complication of **chronic hepatitis B infection**, - It does not develop during the acute phase of the disease. *Liver cirrhosis* - **Liver cirrhosis** is a consequence of **chronic liver injury**, typically evolving over many years due to chronic hepatitis B. - It is not an outcome of acute HBV infection.
Explanation: ***Fecal-oral*** - This patient's symptoms (jaundice, nausea, anorexia) and labs (**positive Anti-HAV IgM**) indicate acute **Hepatitis A virus (HAV)** infection - **HAV** is predominantly transmitted via the **fecal-oral route**, often through contaminated food or water - This is the **most common mode** of transmission, particularly in areas with poor sanitation or through contaminated food handlers *Breast milk* - While some viruses can be transmitted via breast milk, it is **not a common mode** of transmission for acute **Hepatitis A** - **HAV** primarily spreads through contaminated ingestion via the fecal-oral route *Perinatal* - **Perinatal transmission** refers to infection from mother to child during pregnancy or childbirth, which is common for viruses like **HBV or HIV** - **HAV** is not typically transmitted **perinatally** and is not a concern during pregnancy in the same way bloodborne viruses are *Blood transfusion* - **Bloodborne pathogens** like **Hepatitis B, C, or HIV** are transmissible through blood transfusions - **Hepatitis A** is an **enteric virus** and is rarely transmitted via blood transfusions, especially with modern screening practices - Viremia in HAV is transient and brief compared to chronic bloodborne hepatitis viruses *Sexual contact* - Although **HAV** can be transmitted through close person-to-person contact, including sexual contact (particularly among men who have sex with men), it is **not its most common mode of transmission** overall - The primary route remains **fecal-oral**, especially in settings with contaminated food or water - Sexual transmission typically involves fecal-oral exposure during sexual practices
Explanation: ***Hepatitis B virus*** - The patient's symptoms of **fever**, **malaise**, **arthralgia** in large joints, **dark urine**, and **weight loss** are classic signs of **hepatitis B virus (HBV)** infection with **extrahepatic manifestations**. - **Dark urine** indicates **bilirubinuria** from hepatic involvement, confirming liver pathology. - **Arthralgia in large joints** is a well-recognized extrahepatic manifestation of HBV caused by **immune complex deposition** (Type III hypersensitivity). - The **neurological symptoms** (tingling and numbness) strongly suggest **polyarteritis nodosa (PAN)**, a necrotizing vasculitis associated with HBV that commonly causes **mononeuritis multiplex** and peripheral neuropathy. - The history of infection **7 months ago** with ongoing symptoms suggests progression to **chronic HBV infection** with systemic complications. *Mycoplasma pneumoniae* - This infection primarily causes **respiratory symptoms**, such as **atypical pneumonia** ("walking pneumonia"), and is less likely to lead to persistent arthralgia, significant weight loss, or dark urine. - While post-infectious arthralgia can rarely occur, it is not a prominent feature and does not explain the hepatic (dark urine) or neurological manifestations. *Epstein-Barr virus infection* - **Epstein-Barr virus (EBV)** typically causes **infectious mononucleosis**, characterized by **fever**, **fatigue**, **pharyngitis**, **lymphadenopathy**, and **splenomegaly**. - While mild arthralgia can occur, it is not a dominant feature, and **dark urine** (bilirubinuria), **significant weight loss**, and **peripheral neuropathy** are not characteristic of EBV infection. *Yersinia enterocolitica* - Infections with **Yersinia enterocolitica** typically cause **acute gastroenteritis** with **diarrhea**, **abdominal pain**, and sometimes **reactive arthritis** (Reiter syndrome). - **Reactive arthritis** more commonly affects **lower extremity joints** in an **asymmetric pattern** and occurs post-infection, not during active infection. - The **dark urine**, **neuropathy**, and **chronic constitutional symptoms** are not characteristic of Yersinia infection. *Chlamydophila pneumoniae* - This pathogen primarily causes **respiratory tract infections**, similar to Mycoplasma pneumoniae, leading to **atypical pneumonia** or **bronchitis**. - It is not typically associated with chronic arthralgia, significant weight loss, dark urine (hepatic involvement), or neurological symptoms as described in this case.
Explanation: ***Forms a pentamer when secreted*** - The acute presentation of Hepatitis B infection, indicated by the symptoms and IV drug use history, suggests that the **anti-HBc immunoglobulin** being analyzed is predominantly **IgM**. - **IgM antibodies** are classically known to form a **pentamer** structure when secreted, making them very effective at activating the classical complement pathway. *Activates eosinophils* - **Eosinophil activation** is primarily mediated by **IgE antibodies**, which are involved in allergic reactions and parasitic infections, not typically acute viral hepatitis. - While other immune cells are involved in viral immunity, direct eosinophil activation by IgM is not a characteristic feature. *Protects against gastrointestinal infections* - **Protection against gastrointestinal infections** is primarily conferred by **secretory IgA**, which is present in mucosal secretions. - Although IgM plays a role in systemic immunity, it is not the primary immunoglobulin for mucosal defense in the GI tract. *Crosses epithelial cells* - The key immunoglobulin that **crosses epithelial cells** into secretions on mucosal surfaces is **secretory IgA**, often in a dimeric form. - IgM does not have a specialized mechanism for extensive transport across epithelial barriers. *Crosses the placenta* - The only class of immunoglobulin that can **cross the placenta** is **IgG**, providing passive immunity to the fetus. - IgM antibodies are too large to cross the placental barrier.
Explanation: ***Reverse transcription of viral RNA to DNA*** - The description of a virus with **partially double-stranded, circular DNA** that causes acute infection with fever, fatigue, and **scleral icterus** points to **Hepatitis B virus (HBV)**. - HBV is a **hepadnavirus** with a unique replication strategy: despite being a DNA virus, it replicates through an **RNA intermediate** (pregenomic RNA). - The virus uses **reverse transcriptase** to synthesize DNA from this RNA template within the nucleocapsid—making it the only DNA virus that uses reverse transcription in its replication cycle. *Adhesion of virus to host ICAM-1 receptor* - The **intercellular adhesion molecule 1 (ICAM-1) receptor** is primarily used by viruses like **rhinovirus** for entry into host cells, which is not characteristic of HBV. - HBV primarily uses the **sodium taurocholate co-transporting polypeptide (NTCP)** as its entry receptor on hepatocytes. *Cleavage of gp160 to form envelope glycoprotein* - **gp160** is a precursor protein of the **HIV envelope glycoprotein**, which is cleaved into gp120 and gp41, essential for HIV entry. - This process is specific to **retroviruses** like HIV and is not involved in HBV replication. *Bacterial translation of viral DNA* - Viruses, including HBV, replicate within **eukaryotic host cells** and utilize the host cell's machinery for replication, transcription, and translation. - **Bacterial translation** is irrelevant to viral replication in human hosts. *Transcription of viral DNA to RNA in the cytoplasm* - While transcription of viral DNA to RNA does occur in HBV, it primarily takes place in the **nucleus** of the host hepatocyte, not the cytoplasm. - The resulting pregenomic RNA is then exported to the cytoplasm for **reverse transcription** within newly assembled nucleocapsids.
Explanation: ***Needlestick injury*** - The jaundice, scleral icterus, pruritus, and **purpuric rash worsened by sunlight** (suggesting **Porphyria Cutanea Tarda**) are highly indicative of **chronic Hepatitis C virus infection**. - **Hepatitis C** is primarily transmitted through **blood-to-blood contact**, with **needlestick injuries** and intravenous drug use being the most common routes. *Ingestion of raw shellfish* - **Hepatitis A virus** and **Vibrio vulnificus** can be acquired this way, but they typically cause acute, self-limiting illness or severe sepsis, respectively, not chronic liver disease with porphyria. - **Hepatitis A** does not lead to chronic hepatitis or the dermatological manifestations described. *Inhalation of spores* - **Inhalation of spores** is associated with fungal infections like **histoplasmosis** or **coccidioidomycosis**, which do not typically cause chronic hepatitis, jaundice, pruritus, or porphyria cutanea tarda. - These infections primarily affect the lungs, though disseminated forms can occur, they do not match the presented symptoms. *Bathing in freshwater* - **Bathing in freshwater** can transmit pathogens like **Leptospira** or **Schistosoma**, causing leptospirosis or schistosomiasis, respectively. - These infections present with different clinical pictures and are not associated with chronic hepatitis, jaundice, or porphyria cutanea tarda. *Sexual contact* - While **Hepatitis C** can be transmitted sexually, this route is significantly **less efficient** than blood-to-blood contact. - **Hepatitis B** is more commonly associated with sexual transmission and can also cause chronic liver disease, but the presence of **Porphyria Cutanea Tarda** is a characteristic extrahepatic manifestation strongly associated with **chronic Hepatitis C infection**. - Given the clinical presentation, **needlestick injury or intravenous drug use** (blood-borne transmission) is the most likely route of HCV acquisition.
Explanation: **Viral RNA polymerase lacks proofreading ability** - The clinical presentation (fatigue, myalgia, pruritic skin rash, history of blood transfusions, scleral icterus, right upper abdominal tenderness) and lab findings (elevated replication rate of a hepatotropic virus, high variability in genetic sequence of glycosylated envelope proteins) are highly suggestive of **Hepatitis C Virus (HCV)** infection. - HCV is an RNA virus, and its **RNA-dependent RNA polymerase lacks proofreading capability**. This leads to a high mutation rate, particularly in the envelope genes, allowing the virus to evade the host immune system and making vaccine development challenging. *Infection with multiple viral genotypes* - While coinfection with multiple genotypes can occur and contribute to overall viral diversity, the question specifically asks for the explanation of **variability within the genetic sequence** encoding envelope proteins, implying a mechanism of genetic change rather than simply the presence of different strains. - The primary mechanism for the high *de novo* variability seen in HCV envelope proteins is the error-prone replication process, not just the co-occurrence of multiple genotypes. *Neutralizing host antibodies induce viral genome mutations* - Host antibodies can exert **selective pressure** on viruses, favoring the survival of mutants that can evade immune recognition. However, this is a secondary driver of diversity, operating on mutations generated by replication errors. - The fundamental reason for the *high rate* of mutation in HCV, which then allows for such immune evasion, is the lack of proofreading by its RNA polymerase. *Integration of viral genes into host cell genome* - Integration of viral genes into the host genome is characteristic of **retroviruses** (like HIV) or some DNA viruses, not RNA viruses like HCV. - Even in viruses that integrate, this process does not primarily explain the high variability in *envelope protein sequences* through ongoing, rapid mutation. *Incorporation of envelope proteins from a second virus* - This phenomenon, known as **phenotypic mixing**, involves a virus acquiring envelope proteins from a coinfecting unrelated virus. While possible in some contexts, it is not the primary mechanism for the extensive and continuous genetic variability observed in HCV envelope proteins. - The high genetic variability described is an intrinsic characteristic of HCV's replication strategy, not dependent on coinfection with another specific virus contributing its envelope proteins.
Explanation: ***I, II, III*** - **Hepatitis B virus (HBV)** is primarily transmitted through contact with infected **blood** or other bloody body fluids (e.g., semen, vaginal secretions), making routes I (blood) and II (sexual contact) major modes of transmission. - **Maternal-fetal transmission** (route III) can occur during childbirth, especially if the mother has high viral loads, although *in utero* transmission is rare. *II, III* - This option is incorrect because it omits **blood transmission (I)**, which is a major route for HBV spread through shared needles, transfusions, or open wounds. - While sexual and maternal-fetal transmissions are significant, they do not account for all primary modes of spread. *I, II, III, IV* - This option is incorrect because while routes I, II, and III are valid, **breast milk (IV)** is generally *not* considered a significant route for HBV transmission. - Studies have shown a very low, if any, risk of HBV transmission through breast milk, and breastfeeding is typically safe for HBV-positive mothers, especially if the infant is vaccinated. *I, III, IV* - This option is incorrect because it includes **breast milk (IV)**, which is not a clinically significant route of transmission, and it excludes **sexual contact (II)**, a very common mode of HBV spread. - Many HBV infections are acquired through unprotected sexual intercourse with an infected partner. *I only* - This option is incorrect as it severely underrepresents the various transmission routes of HBV, omitting **sexual contact (II)** and **maternal-fetal transmission (III)**. - While blood transmission is critical, HBV is also frequently spread through other bodily fluids and from mother to child.
Explanation: ***Hepatitis C virus*** - **Hepatitis C virus (HCV)** is strongly associated with **lymphoplasmacytic lymphoma (Waldenstrom macroglobulinemia)** and other B-cell non-Hodgkin lymphomas, affecting approximately 15% of patients with this cancer. - The chronic stimulation of B cells by HCV is thought to contribute to lymphoproliferation and eventual malignant transformation. *Human immunodeficiency virus (HIV)* - HIV is primarily associated with **high-grade B-cell lymphomas** such as diffuse large B-cell lymphoma and primary central nervous system lymphoma, often related to immunosuppression and Epstein-Barr virus co-infection. - It is not typically linked to lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia. *Human T cell lymphotropic virus (HTLV)* - **HTLV-1** is the causative agent of **adult T-cell leukemia/lymphoma (ATLL)**, a highly aggressive T-cell malignancy. - HTLV is not known to be associated with B-cell lymphomas like lymphoplasmacytic lymphoma. *Human herpesvirus 8* - **Human herpesvirus 8 (HHV-8)**, also known as Kaposi sarcoma-associated herpesvirus (KSHV), is etiologically linked to **Kaposi sarcoma**, **primary effusion lymphoma**, and multicentric Castleman disease. - It does not have a direct association with lymphoplasmacytic lymphoma. *Epstein-Barr virus* - **Epstein-Barr virus (EBV)** is implicated in several lymphoid malignancies, including **Burkitt lymphoma**, Hodgkin lymphoma, and often in lymphomas seen in immunosuppressed individuals. - While EBV can be found in some lymphomas, it is not a primary association for lymphoplasmacytic lymphoma.
Explanation: ***Chronically infected, low infectivity*** - The presence of **HBsAg positive** for more than 6 months indicates **chronic HBV infection**. The presence of **anti-HBeAg antibody** and **negative HBeAg** suggests **low viral replication activity** and thus low infectivity. - **HBeAg negativity** along with positivity for **HBV DNA** (if tested, though not provided here) would further differentiate this state as **"HBeAg-negative chronic hepatitis B,"** which typically implies lower, but still present, infectivity compared to HBeAg-positive chronic infection. *Immune due to previous infection* - Immunity due to previous infection is characterized by **negative HBsAg** and **positive anti-HBsAg antibody**, along with **positive anti-HBcAg IgG**. - This patient, however, is **HBsAg positive** and **anti-HBsAg antibody negative**, ruling out resolved infection. *Immune due to previous vaccination* - Immunity due to vaccination is characterized by **negative HBsAg**, **positive anti-HBsAg antibody**, and **negative anti-HBcAg antibody** (both IgM and IgG). - This patient has **positive HBsAg** and **positive anti-HBcAg IgG**, indicating either current or past infection, not vaccination-induced immunity. *Acutely infected* - **Acute infection** is characterized by **positive HBsAg**, **negative anti-HBsAg antibody**, and typically **positive anti-HBcAg IgM**. - This patient has **negative anti-HBcAg IgM**, which makes acute infection unlikely, as IgM antibodies are present early in acute infection. *Chronically infected, high infectivity* - **High infectivity** in chronic HBV infection is typically indicated by **positive HBsAg** and **positive HBeAg**, often with high levels of HBV DNA. - This patient is **HBeAg negative** and **anti-HBeAg antibody positive**, indicating a lower level of viral replication and thus lower infectivity.
Explanation: ***Hepatitis B virus*** - The **Hepatitis B vaccine** is routinely given at birth and contains a **noninfectious glycoprotein** (HBsAg) that elicits an immune response. - This vaccine is crucial for preventing mother-to-child transmission and provides long-term protection against **Hepatitis B infection**. *Bordetella pertussis* - The vaccine for **Bordetella pertussis** (whooping cough) is part of the DTaP vaccine and is typically given at 2 months of age, not at birth. - The DTaP vaccine usually contains **inactivated toxins** or acellular components, not solely a glycoprotein. *Rotavirus* - The **Rotavirus vaccine** is an **oral live-attenuated vaccine** administered in two or three doses, with the first dose typically given at 2 months of age. - It does not contain a noninfectious glycoprotein. *Poliovirus* - The **Poliovirus vaccine** (IPV) is an **inactivated vaccine** given at 2 months of age, and the **oral poliovirus vaccine (OPV)** is a live-attenuated vaccine. - Neither is routinely given at birth, nor described as a noninfectious glycoprotein. *Haemophilus influenzae type b* - The **Haemophilus influenzae type b (Hib) vaccine** is a polysaccharide-protein conjugate vaccine, first administered at 2 months of age. - While it contains a protein component, it is not typically given at birth.
Explanation: **Hepatitis B virus** - Hepatitis D virus is a **defective RNA virus** that requires co-infection with the **Hepatitis B virus** for its replication and expression. - The description of the virus as an **enveloped, negative-sense, single-stranded, closed circular RNA virus** specifically matches the characteristics of Hepatitis D virus (HDV). *Hepatitis C virus* - Although Hepatitis C virus (HCV) can cause similar symptoms and is common among intravenous drug users, it is a **positive-sense RNA virus** and does not require co-infection with another hepatitis virus. - HCV infection does not fit the specific viral description provided in the question. *Hepatitis A virus* - Hepatitis A virus (HAV) is an **unenveloped, positive-sense RNA virus** typically transmitted via the fecal-oral route, and it does not require co-infection with another virus. - Its viral characteristics and transmission route do not match the clinical scenario. *Hepatitis D virus* - Hepatitis D virus (HDV) is described in the question as the infecting agent (enveloped, negative-sense, single-stranded, closed circular RNA virus). However, it is a **defective virus** and requires **Hepatitis B virus (HBV)** for its replication. - Therefore, while HDV is the direct cause of the current disease, HBV must also be present for HDV to establish infection. *Hepatitis E virus* - Hepatitis E virus (HEV) is an **unenveloped, positive-sense RNA virus** mainly transmitted via the fecal-oral route, similar to HAV. - It does not require co-infection with another virus and its viral characteristics do not match the description.
Explanation: ***She has not been vaccinated against the hepatitis B virus.*** - A **negative Anti-HBs** indicates a lack of protective antibodies developed either through vaccination or past infection. - A **negative Anti-HBc IgG** and **IgM** further confirms no prior exposure to the hepatitis B core antigen, which would be present with natural infection. *She recovered from a hepatitis B virus infection.* - Recovery from HBV infection would typically show **positive Anti-HBs** and **positive Anti-HBc IgG**, neither of which are present here. - The absence of **Anti-HBc antibodies** rules out past natural infection, whether resolved or chronic. *She is infected with the hepatitis D virus.* - Hepatitis D virus (HDV) infection only occurs in the presence of an active **Hepatitis B virus (HBV) infection**. - The student's **HBsAg negative** status indicates no active HBV infection, thereby ruling out HDV. *She can transmit the hepatitis A virus.* - **Anti-HAV IgG positive** indicates prior exposure to HAV or vaccination, leading to immunity. - **Anti-HAV IgM negative** suggests no acute HAV infection, meaning she is not currently infectious. *She is an asymptomatic carrier of the hepatitis B virus.* - An asymptomatic carrier of HBV would have **positive HBsAg** and likely **positive Anti-HBc IgG**, but both are negative in this case. - The absence of **HBsAg** definitively rules out an active carrier state.
Explanation: ***IgM*** - Upon initial exposure to an antigen (like in the first vaccine dose), **IgM antibodies** are the first class to be produced and secreted by plasma cells. - This **primary immune response** is characterized by a rapid, but short-lived, **IgM** peak. *IgE* - **IgE antibodies** are primarily involved in **allergic reactions** and defense against parasites, not the initial response to vaccination. - Their production is typically triggered by exposure to specific allergens or parasites and mediated by Th2 helper T cells. *IgG* - **IgG antibodies** are the most abundant class in serum and are produced later in the primary response and predominantly during the **secondary immune response**. - They provide **long-term immunity** and can cross the placenta, but are not the first antibody produced after initial antigen exposure. *IgD* - **IgD antibodies** are mainly found on the surface of **naive B cells** and act as B-cell receptors, playing a role in B-cell activation. - They are not secreted in significant amounts into the serum and thus are not the first circulating antibody produced after vaccination. *IgA* - **IgA antibodies** are primarily found in **mucosal secretions** (e.g., saliva, tears, breast milk, gastrointestinal fluid) and play a key role in mucosal immunity. - They are not the first antibody produced systemically in response to an initial vaccine exposure.
Explanation: ***Hepatitis C infection*** - The combination of **intravenous drug use**, **fever**, **joint pain**, **palpable purpura**, **positive rheumatoid factor**, and **positive serum cryoglobulins** is highly suggestive of **mixed cryoglobulinemia**, which is most commonly associated with chronic **Hepatitis C virus (HCV) infection**. - **Cryoglobulinemia** is a systemic vasculitis caused by immune complex deposition, a common extrahepatic manifestation of HCV. *Dermatomyositis* - Characterized by **proximal muscle weakness** and characteristic skin rashes (e.g., **Gottron's papules**, **heliotrope rash**), which are not described here. - While dermatomyositis can be associated with inflammatory markers, it typically does not present with palpable purpura or positive cryoglobulins. *Systemic lupus erythematosus (SLE)* - While SLE can cause **fever**, **arthralgia**, and a **rash**, the patient's **negative antinuclear antibody (ANA)** makes SLE highly unlikely. - **Cryoglobulinemia** is rare in SLE, and the specific finding of palpable purpura points away from typical SLE rashes. *HIV infection* - HIV can cause a variety of skin lesions and arthralgias, but **palpable purpura** and **mixed cryoglobulinemia** are not its primary or most common manifestations. - While **rheumatoid factor** can be positive in HIV, the overall clinical picture strongly favors HCV-associated cryoglobulinemia. *Hepatitis B infection* - Hepatitis B can be associated with **vasculitis** (e.g., **polyarteritis nodosa**) and immune complex-mediated disease. - However, **mixed cryoglobulinemia**, characterized by the specific combination of symptoms and laboratory findings presented, is overwhelmingly more associated with **Hepatitis C** than Hepatitis B.
Explanation: ***B lymphocyte induced maturation protein 1 (BLIMP1)*** - The positive **anti-hepatitis A IgM** and negative **IgG** indicates an **acute hepatitis A infection**, triggering a primary immune response where **B cells differentiate into plasma cells** to produce antibodies. - **BLIMP1** (B lymphocyte-induced maturation protein 1) is a master regulator that promotes plasma cell differentiation by **repressing key B cell transcription factors** and activating plasma cell-specific genes. *Metastasis-associated 1 family, member 3 (MTA-3)* - **MTA-3** is a component of the **NuRD corepressor complex** and is involved in various cellular processes including transcriptional repression and chromatin remodeling. - While it plays a role in B cell development and germinal center reactions, it is **not directly required for the terminal differentiation of B cells into plasma cells**; instead, it is involved in maintaining germinal center B cell identity. *Microphthalmia-associated transcription factor (MITF)* - **MITF** is a transcription factor primarily known for its role in the **development and function of melanocytes**, mast cells, and osteoclasts. - It is **not involved in the differentiation of B cells into plasma cells** in the context of an immune response. *Paired box protein 5 (PAX5)* - **PAX5** is a crucial transcription factor for **B cell development** and maintaining B cell identity, acting as a repressor of non-B cell lineages. - Its expression must be **downregulated for B cells to differentiate into plasma cells**, as it inhibits the plasma cell differentiation program. *B cell lymphoma 6 (BCL6)* - **BCL6** is a transcriptional repressor critical for the **formation and maintenance of germinal centers**, where B cells undergo proliferation, somatic hypermutation, and class-switch recombination. - It **inhibits plasma cell differentiation**, and its downregulation is necessary for B cells to commit to becoming plasma cells.
Explanation: ***Ribonucleic acids*** - The description of isolating "viral genomic material," which is then "enzymatically cleaved" and run on a "formaldehyde agarose gel," followed by the application of "targeted probes" and X-ray visualization, perfectly matches the technique of **Northern blotting**. - Northern blotting is used to detect and quantify specific **RNA sequences**, which is consistent with the hepatitis C virus being an RNA virus. *Lipid-linked oligosaccharides* - These molecules are involved in protein glycosylation and are typically analyzed using techniques like **mass spectrometry** or **chromatography**, not Northern blotting. - They are not nucleic acid material, which is implied by "viral genomic material" and enzymatic cleavage steps. *Transcription factors* - **Transcription factors** are proteins that regulate gene expression and would typically be identified using techniques like **Western blotting** (for protein detection) or Electrophoretic Mobility Shift Assay (EMSA) for DNA binding. - They are not directly "genomic material" that would be cleaved and run on an agarose gel in this manner. *Polypeptides* - **Polypeptides** are chains of amino acids, i.e., proteins, which are normally detected using **Western blotting** after separation on an SDS-PAGE gel. - The use of "formaldehyde agarose gel" and "enzymatic cleavage" points specifically to nucleic acid analysis, not protein analysis. *Deoxyribonucleic acids* - While DNA is genomic material and is often analyzed similarly, the use of a **formaldehyde agarose gel** is characteristic of RNA electrophoresis because formaldehyde prevents RNA from forming secondary structures. - Furthermore, hepatitis C is a **single-stranded RNA virus**, meaning its genome is RNA, not DNA.
Explanation: **HBsAg and Anti-HBc IgM** - The described symptoms (jaundice, fatigue, nausea, RUQ tenderness, elevated AST/ALT in the thousands) are highly suggestive of **acute viral hepatitis**, particularly given the patient's inconsistent condom use and recent travel to China. - **Hepatitis B surface antigen (HBsAg)** indicates active infection, and **Hepatitis B core IgM antibody (Anti-HBc IgM)** signifies acute or recent infection, making these the most appropriate initial diagnostic tests. *Reassurance and counselling* - This patient presents with significant symptoms and abnormal liver function tests indicating acute liver injury, which requires immediate investigation and management, not just reassurance. - Delaying diagnosis and treatment for acute hepatitis can lead to severe complications. *USG of the abdomen* - While an abdominal ultrasound can evaluate the liver and biliary system for structural abnormalities, it is less likely to be the *initial* best step in a patient with a strong clinical picture for acute viral hepatitis and markedly elevated transaminases. - An ultrasound would be more pertinent if **biliary obstruction** or **fatty liver disease** were higher on the differential, which is not strongly supported by these lab values. *CT scan of the abdomen* - A CT scan offers detailed imaging but is generally not the first-line investigation for suspected acute viral hepatitis. - It would be considered if there was concern for **abscess**, **tumor**, or complex intra-abdominal pathology, which is not indicated by the current presentation. *ERCP* - **Endoscopic retrograde cholangiopancreatography (ERCP)** is an invasive procedure primarily used for therapeutic intervention in cases of **biliary obstruction**, such as removing gallstones or placing stents. - It is not indicated as a diagnostic step for acute viral hepatitis, especially before less invasive and more specific tests have been performed.
Explanation: ***Chronic infection*** - This patient demonstrates **occult or HBsAg-negative chronic hepatitis B**, a rare variant of chronic infection characterized by **positive HBV DNA with negative HBsAg**. - The presence of **detectable HBV DNA** confirms active viral replication despite the absence of HBsAg, which can occur due to mutations in the S gene or immune pressure suppressing HBsAg production. - The **positive HBcAb** (IgG anti-HBc) indicates prior exposure, and combined with detectable viral DNA, confirms chronic infection rather than resolved infection. - The patient's **high-risk behaviors** (MSM, IV drug use) and **lack of vaccination** are consistent risk factors for acquiring hepatitis B. - **HBeAg-negative** status indicates this is likely HBeAg-negative chronic hepatitis B, which can still have significant viral replication. *Immune from vaccine* - Vaccine-induced immunity shows **positive HBsAb** with **negative HBcAb** (no natural exposure). - This patient has **negative HBsAb** and **positive HBcAb**, incompatible with vaccine immunity. - The patient explicitly states he has **never received the hepatitis B vaccine**. *Acute infection* - Acute infection typically presents with **positive HBsAg** and **positive IgM anti-HBc** (not just total HBcAb). - The **negative HBsAg** and absence of IgM markers make acute infection unlikely. - The chronic fatigue over months (not acute illness) also suggests chronic rather than acute disease. *Convalescent (window) period* - The window period occurs between disappearance of HBsAg and appearance of HBsAb, characterized by **positive IgM anti-HBc** as the only marker initially. - This patient has **positive HBV DNA**, indicating active replication, which rules out the window period where the virus is being cleared. - **Negative HBsAb** without eventual seroconversion after months of symptoms makes window period unlikely. *Immune from natural infection* - Immunity from resolved natural infection shows **positive HBsAb** and **positive HBcAb** with **negative HBV DNA**. - This patient has **positive HBV DNA** (active replication) and **negative HBsAb** (no immunity), confirming ongoing infection rather than resolved disease. - The presence of viral DNA definitively rules out immune clearance.
Explanation: ***HBsAg +, Anti-HBsAg -, Anti-HBcAg IgM -, Anti-HBcAg IgG +, HBeAg +, Anti-HBeAg -*** - The presence of **HBsAg for more than six months** is the hallmark of chronic hepatitis B infection. The absence of **Anti-HBs** indicates a lack of resolved infection or vaccination. - The presence of **IgG anti-HBc** and absence of **IgM anti-HBc** further confirms chronic infection, as IgM anti-HBc is indicative of acute infection. **HBeAg positivity** suggests active viral replication and higher infectivity. *HBsAg -, Anti-HBsAg +, Anti-HBcAg IgM -, Anti-HBcAg IgG +, HBeAg -, Anti-HBeAg +* - This profile indicates **resolved HBV infection** or successful vaccination. The presence of **Anti-HBs** signifies immunity. - The absence of **HBsAg** means the virus is no longer actively replicating in the liver. *HBsAg +, Anti-HBsAg -, Anti-HBcAg IgM +, Anti-HBcAg IgG -, HBeAg +, Anti-HBeAg -* - This panel is classic for an **acute HBV infection**. The presence of **HBsAg** and **IgM anti-HBc** indicates a recent and active infection. - **HBeAg positivity** in this context points to active viral replication during the acute phase. *HBsAg -, Anti-HBsAg -, Anti-HBcAg IgM +, Anti-HBcAg IgG -, HBeAg -, Anti-HBeAg +* - This rare profile, sometimes referred to as the "**window period**," indicates acute infection where **HBsAg** has cleared but **Anti-HBs** has not yet appeared. The presence of **IgM anti-HBc** confirms recent infection. - The absence of **HBsAg** and presence of **Anti-HBe** during this phase can be misleading if not interpreted with other markers. *HBsAg -, Anti-HBsAg +, Anti-HBcAg IgM -, Anti-HBcAg IgG -, HBeAg -, Anti-HBeAg -* - This profile is most consistent with **immunity due to vaccination**. The presence of **Anti-HBs** is from the vaccine, and there is no evidence of previous or current infection (no anti-HBc). - The absence of all other markers excludes natural infection history.
Explanation: ***Hepatitis B*** - This patient's presentation is **classic for acute hepatitis B infection**. The key diagnostic feature is the **serum sickness-like prodrome** that occurred 6 weeks ago, characterized by **fever, arthralgia, lymphadenopathy, and urticarial rash**. - This prodromal syndrome results from **circulating immune complexes** (HBsAg-antibody complexes) and is a **hallmark of Hepatitis B**, occurring in 10-20% of acute HBV cases during the pre-icteric phase. - The timeline fits perfectly: **exposure 2 months ago** (travel to Colombia) → **prodrome at 6 weeks** (4-10 weeks post-exposure is typical) → **icteric phase now** (jaundice with scleral icterus). - Hepatitis B can be transmitted through **sexual contact, needlestick injuries, or exposure to contaminated instruments** during travel, making it highly relevant in this travel context. *Hepatitis A* - While hepatitis A is common in travelers to endemic areas and causes acute hepatitis, it **does NOT typically present with the serum sickness-like prodrome** described here. - HAV prodrome is usually **nonspecific** (malaise, anorexia, nausea) and does **not include arthralgia, lymphadenopathy, or urticarial rash**. - The described prodromal syndrome with rash and joint pain is **pathognomonic for HBV**, not HAV. *Borrelia burgdorferi* - This bacterium causes **Lyme disease**, characterized by **erythema migrans** (expanding target lesion), not an urticarial rash. - Lyme disease does not cause **acute hepatitis with jaundice** or the icteric presentation seen here. - Not consistent with the clinical timeline or hepatic involvement. *Enterotoxigenic E. coli* - ETEC causes **traveler's diarrhea** with watery stools, cramping, and nausea, typically within days of exposure. - Does **not cause hepatitis**, jaundice, or a prodromal syndrome with rash and arthralgia. - Symptoms resolve within 3-5 days without hepatic involvement. *Campylobacter jejuni* - Causes **bacterial gastroenteritis** with bloody diarrhea, fever, and abdominal pain. - Does **not cause acute hepatitis** with jaundice or the serum sickness-like prodrome described. - While travel-associated, it does not explain the hepatic and systemic findings.
Explanation: ***HBsAb*** - A positive **HBsAb** (Hepatitis B surface antibody) indicates immunity to hepatitis B virus, either from successful **vaccination** or **recovery from past infection**. - This antibody provides **protective immunity** against future HBV infection and is the definitive marker of immunity. *HBeAb* - **HBeAb** (Hepatitis B e antibody) indicates **seroconversion** from HBeAg during chronic HBV infection, suggesting lower viral replication. - It does **not confer immunity** against the virus itself and only reflects a phase of chronic infection. *HBeAg* - **HBeAg** (Hepatitis B e antigen) indicates **active viral replication** with high infectivity during ongoing hepatitis B infection. - Its presence signifies a **replicative phase** of infection and increased risk of transmission to others. *HBsAg* - **HBsAg** (Hepatitis B surface antigen) indicates **active hepatitis B infection**, whether acute or chronic. - This antigen is the **first serologic marker** to appear following exposure and confirms presence of the virus. *HBcAb* - **HBcAb** (Hepatitis B core antibody) indicates **previous or current exposure** to hepatitis B virus. - It does **not differentiate** between acute, chronic, or resolved infection and does not confer protective immunity.
Explanation: ***It exists as a monomer*** - In a recovered hepatitis B infection, **anti-HBc IgG** antibodies are prominent, indicating past exposure and immunity. - **IgG** is the most abundant immunoglobulin in serum and exists primarily as a **monomer**, providing long-term immunity. *It exists as a dimer* - This characteristic primarily describes **secretory IgA**, which is found in mucosal secretions like tears, saliva, and breast milk. - While IgA can be involved in host defense, it's not the primary antibody subtype associated with sustained immunity after hepatitis B recovery, nor does it typically target the **core antigen** in this context. *It is only activated by multivalent immunogens* - This statement is more characteristic of **IgM**, which often requires multiple binding sites to activate complement efficiently due to its pentameric structure. - **IgG** can bind to both univalent and multivalent antigens and is effective in neutralizing pathogens and activating other immune responses. *It exists as a pentamer* - This describes **IgM**, which is typically the first antibody produced during a primary immune response and is found on the surface of B cells. - In a recovered infection, IgM would have largely subsided, replaced by **IgG**. *It activates mast cells* - This is a hallmark function of **IgE**, which binds to receptors on mast cells and basophils, triggering the release of histamine and other mediators in allergic reactions. - **IgG** has different effector functions, such as opsonization, neutralization, and complement activation.
Explanation: ***Immune due to infection*** - The presence of **anti-HBc IgG** along with **anti-HBsAb** in the absence of **HBsAg** indicates past resolution of HBV infection. - This combination confers **natural immunity** following a prior exposure, distinguishing it from vaccine-induced immunity (which would lack anti-HBc IgG). *Window period* - This period is characterized by the absence of **HBsAg** and **anti-HBsAb**, with the only positive marker being **anti-HBc IgM**. - The patient's results show positive **anti-HBsAb** and **anti-HBc IgG**, which rule out a window period. *Chronic infection* - Chronic infection is defined by the persistence of **HBsAg** for more than six months. - The patient's **HBsAg is negative**, therefore excluding chronic infection. *Acute infection* - Acute infection would be evidenced by the presence of **HBsAg** and often **anti-HBc IgM**. - Both **HBsAg** and **anti-HBc IgM** are negative in this patient, ruling out acute infection. *Immune due to vaccination* - Vaccination leads to the development of **anti-HBsAb** but does not produce **anti-HBc antibodies**. - The presence of **anti-HBc IgG** in this patient indicates exposure to the complete virus, not just vaccination.
Explanation: ***HBsAg*** - **Hepatitis D virus (HDV)** is a **defective virus** that requires co-infection with **hepatitis B virus (HBV)** to complete its replication cycle. - Specifically, HDV uses the **hepatitis B surface antigen (HBsAg)**, encoded by HBV, to form its **outer envelope** and assemble viable virions. *HBV DNA polymerase* - HBV DNA polymerase is essential for **HBV DNA replication**, converting the viral pregenomic RNA into DNA. - It plays no direct role in the **packaging or formation of the HDV envelope**. *HBV RNA polymerase* - HBV, like other DNA viruses, utilizes the **host cell's RNA polymerase** for transcription of its RNA templates, not its own. - HBV itself does not encode an RNA polymerase, and even if it did, it would not be relevant for HDV virion packaging. *HBcAg* - **Hepatitis B core antigen (HBcAg)** forms the **capsid** of the HBV virion, encapsulating the viral genome. - While critical for HBV replication, it is **not incorporated into the HDV virion outer envelope**. *HBeAg* - **Hepatitis B e-antigen (HBeAg)** is a soluble protein derived from **HBcAg** that is secreted into the blood. - It plays a role in **immune modulation** and is a marker of HBV replication but does not contribute to HDV virion assembly.
Explanation: ***Deltavirus*** - The presence of both **partially double-stranded DNA virions** (Hepatitis B virus) and **single-stranded RNA virions** (Hepatitis D virus) sharing an identical lipoprotein envelope is pathognomonic for **coinfection with Hepatitis B and Deltavirus (HDV)** [1]. - **Hepatitis D (Deltavirus)** is a **defective RNA virus** that is obligately dependent on **Hepatitis B surface antigen (HBsAg)** for its replication, assembly, and transmission—explaining why both viruses share the same lipoprotein envelope [1]. - This coinfection or superinfection with HDV causes **more severe acute hepatitis** and higher rates of **fulminant hepatic failure** compared to HBV alone, consistent with the patient's presentation of jaundice, confusion (hepatic encephalopathy), and GI bleeding [1]. - The patient's **IV drug use** is a key risk factor for both HBV and HDV transmission [1]. *Filovirus* - **Filoviruses** (e.g., Ebola, Marburg) cause **viral hemorrhagic fever** with severe bleeding manifestations and can present with bloody stools. - However, they are **single-stranded RNA viruses** only and do not involve coinfection with a DNA virus, nor do they share envelopes with DNA viruses. - Geographic exposure and clinical context (African hemorrhagic fever outbreaks) would be expected. *Calicivirus* - **Caliciviruses** (e.g., Norovirus, Sapovirus) are **non-enveloped, single-stranded RNA viruses** that cause acute **gastroenteritis** with vomiting and diarrhea. - They do not cause hepatitis with jaundice and hepatic encephalopathy, nor do they involve DNA virus coinfection or envelope sharing. *Hepevirus* - **Hepatitis E virus (Hepevirus)** is a **non-enveloped, single-stranded RNA virus** that causes acute hepatitis, primarily through **fecal-oral transmission** (contaminated water). - While it causes liver disease, it does not involve coinfection with a DNA virus or envelope sharing, and it is not typically associated with IV drug use. - It can cause severe disease in pregnant women but does not explain the dual genome findings. *Herpesvirus* - **Herpesviruses** are **enveloped, double-stranded DNA viruses** that cause various infections (HSV, VZV, EBV, CMV). - While they have DNA genomes and envelopes, they do not coinfect with RNA viruses sharing the same envelope structure, nor are they typically associated with acute severe hepatitis in IV drug users. - Hepatitis from CMV or EBV would have different serologic and molecular findings.
HBV structure and replication
Practice Questions
HBV serological markers
Practice Questions
Acute hepatitis B
Practice Questions
Chronic hepatitis B phases
Practice Questions
HBV treatment indications and options
Practice Questions
HBV vaccination and prevention
Practice Questions
HCV structure and genotypes
Practice Questions
HCV diagnostic testing
Practice Questions
Natural history of HCV infection
Practice Questions
Direct-acting antivirals for HCV
Practice Questions
HCV resistance and treatment failure
Practice Questions
HBV/HCV co-infection
Practice Questions
HCC screening in viral hepatitis
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free